It looks like your message might be empty. Could you clarify your question or provide more details about what you need help with? I'm here to assist! .
ByAinvest
Wednesday, Nov 5, 2025 10:23 am ET1min read
SXTC--
China SXT Pharmaceuticals surged 20.65% intraday, as the company announced the issuance of 90 million new shares in June 2025 to raise funds. The company, which specializes in the research, development, production, and sales of traditional Chinese medicine products (including advanced, refined, and standard TCMP), reported in its 2025 annual filing submitted on July 31 that its client base spans 57 pharmaceutical companies, 14 chain pharmacies, and 16 hospitals across five provinces.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet